|
| 37774897 | Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. | Clin Chim Acta | 2023 |
| 36376460 | Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer. | Sci Rep | 2022 |
| 34137725 | Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer. | JMIR Med Inform | 2021 |
| 33893071 | Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. | Cancer Prev Res (Phila) | 2021 |
| 28376184 | A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. | J Natl Cancer Inst | 2017 |
| 27486767 | Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. | Oncotarget | 2016 |
| 25304377 | Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. | Cancer Lett | 2015 |
| 26431551 | Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. | PLoS One | 2015 |
| 23661430 | Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. | Mol Carcinog | 2014 |
| 25261235 | DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity. | Cancer Res | 2014 |
| 25258651 | Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. | J Cancer | 2014 |
| 24890125 | Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer. | J Pathol | 2014 |
| 23415753 | VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer. | Mol Oncol | 2013 |
| 23838884 | DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition. | Cancer Discov | 2013 |
| 21656579 | A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. | Mol Carcinog | 2012 |
| 21071578 | A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. | Cancer Prev Res (Phila) | 2011 |
| 21697764 | Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. | Pancreas | 2011 |
| 19910837 | Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. | Pancreas | 2010 |
| 20530239 | Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients. | Carcinogenesis | 2010 |
| 19020940 | Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. | Ann Surg Oncol | 2009 |
| 19723895 | MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. | Cancer Prev Res (Phila) | 2009 |
| 19536326 | DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. | PLoS Med | 2009 |
| 18345035 | Targeted disruption of Aurora A causes abnormal mitotic spindle assembly, chromosome misalignment and embryonic lethality. | Oncogene | 2008 |
| 18694622 | Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. | Cancer Lett | 2008 |
| 17505013 | Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. | Clin Cancer Res | 2007 |
| 17624313 | Fine mapping of the NRC-1 tumor suppressor locus within chromosome 3p12. | Biochem Biophys Res Commun | 2007 |
| 11929809 | High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. | Cancer Res | 2002 |
| 12237927 | Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors. | Cancer | 2002 |
| 11170278 | Chromosome 18 suppresses the tumorigenicity of prostate cancer cells. | Genes Chromosomes Cancer | 2001 |
| 11175342 | Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer. | Oncogene | 2000 |
| 9973962 | Limited nonrandom chromosomal aberrations in a recurrent adenoid cystic carcinoma of the parotid gland. | Cancer Genet Cytogenet | 1999 |
| 10459346 | Cytogenetic analysis of a primary salivary gland myoepithelioma. | Cancer Genet Cytogenet | 1999 |
| 10232606 | The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. | Cancer Res | 1999 |
| 9721855 | Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12. | Cancer Res | 1998 |
| 9488521 | Surgical decision-making affected by clinical and genetic screening of a novel kindred with von Hippel-Lindau disease and pancreatic islet cell tumors. | Ann Surg | 1998 |
| 9428361 | Multiple unrelated translocations in a metastatic epimyoepithelial carcinoma of the parotid gland. | Cancer Genet Cytogenet | 1998 |
| 9844608 | Concurrent cytogenetic, interphase fluorescence in situ hybridization and DNA flow cytometric analyses of a carcinoma ex-pleomorphic adenoma of parotid gland. | Cancer Genet Cytogenet | 1998 |
| 9365833 | Suppression of transformed phenotype and tumorigenicity after transfer of chromosome 4 into U251 human glioma cells. | Genes Chromosomes Cancer | 1997 |
| 8630227 | Metastasis suppressor genes for prostate cancer. | Prostate Suppl | 1996 |
| 9245337 | Production of Microcell Hybrids | Methods | 1996 |
| 8957080 | An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. | Oncogene | 1996 |
| 8689608 | Genotypic characterization of a primary mucoepidermoid carcinoma of the parotid gland by cytogenetic, fluorescence in situ hybridization, and DNA ploidy analysis. | Cancer Genet Cytogenet | 1996 |
| 8646736 | A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality. | Cancer Genet Cytogenet | 1996 |
| 8641130 | Report of the sixth international workshop on human chromosome 3 mapping 1995. | Cytogenet Cell Genet | 1996 |
| 8637912 | Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter-q11. | Proc Natl Acad Sci U S A | 1996 |
| 7664340 | MSX1 inhibits myoD expression in fibroblast x 10T1/2 cell hybrids. | Cell | 1995 |
| 8531682 | Microcell fusion. | Methods Enzymol | 1995 |
| 8527392 | Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. | Genes Chromosomes Cancer | 1995 |
| 8619133 | Gene expression in response to retinoic acid in novel human chromosome 21 monochromosomal cell hybrids. | Somat Cell Mol Genet | 1995 |
| 7923075 | Trisomy 5 as the sole chromosomal abnormality in a primary mucoepidermoid carcinoma of the minor salivary gland. | Cancer Genet Cytogenet | 1994 |